Alzamend Neuro's total assets for Q were $1.67M, an increase of 164.39% from the previous quarter. ALZN total liabilities were $2.88M for the fiscal quarter, a -10.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.